Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) EBT: 2009-2019

Historic EBT for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2019 value amounting to $46.5 million.

  • Neurocrine Biosciences' EBT rose 153.42% to $30.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $58.1 million, marking a year-over-year decrease of 43.94%. This contributed to the annual value of $46.5 million for FY2019, which is 113.09% up from last year.
  • Neurocrine Biosciences' EBT amounted to $46.5 million in FY2019, which was up 113.09% from $21.8 million recorded in FY2018.
  • Neurocrine Biosciences' EBT's 5-year high stood at $46.5 million during FY2019, with a 5-year trough of -$142.5 million in FY2017.
  • Moreover, its 3-year median value for EBT was $21.8 million (2018), whereas its average is -$24.7 million.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 52.90% in 2016, then spiked by 115.32% in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' EBT stood at -$92.3 million in 2015, then crashed by 52.90% to -$141.1 million in 2016, then decreased by 1.03% to -$142.5 million in 2017, then soared by 115.32% to $21.8 million in 2018, then surged by 113.09% to $46.5 million in 2019.